feed,title,long_url,short_url
SeekingAlpha,Radient Technologies amends terms of $8.5M loan facility,https://seekingalpha.com/news/3820556,
SeekingAlpha,4D Molecular doses first patient in phase 1/2 trial of 4D-710 for treating cystic fibrosis,https://seekingalpha.com/news/3820551,
